- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02967016
Physical Activity After a Normal Spontaneous or Cesarean Delivery
A Pilot Study: To Compare Physical Activity After a Normal Spontaneous or Cesarean Delivery by Use of a Actigraph GT3X
Studieöversikt
Detaljerad beskrivning
Cesarean delivery is the most common surgery performed in the United States. Despite this fact, there is a paucity of literature looking into the implementation of enhanced recovery after surgery (ERAS) for patients undergoing this type of surgery. ERAS protocols have shown to improve recovery from surgery, decreasing complication and hospital length of stay. The pathway for enhanced recovery targets improving 3 factors that have been associated with increased hospital length of stay and complications. These factors are pain, immobilization and postoperative ileus. These factors, many times are inter-related. A patient in pain would tend not to ambulate as this may exacerbate the pain and discomfort. In order to alleviate pain, the patient would most likely receive an opioid for pain management and these medications are known to have undesirable side effects such as nausea, vomiting, sedation, respiratory depression, constipation and urinary retention. All of these adverse effects (AEs) may lead to complications or increased hospital length of stay.
To the best of the investigators knowledge the average level of physical activity (PA) of parturients recovering from a cesarean delivery or after a normal spontaneous vaginal delivery (NSVD) remains unknown. Taking in consideration that parturients are in a hypercoagulable state and that obstetric venous thromboembolism (VT) is one of the most common causes of maternal morbidity and mortality, ambulation is of utmost importance to anesthesiologists as well as obstetricians. In order to promote mobility, first we need to learn the average parturients level of physical acuity in the immediate post-partum period and up to 48 hours after delivery. This information may help us promote mobility in the immediate postpartum period, particularly for those that underwent a cesarean delivery since they are at higher risk of VT.
Given the lack of knowledge regarding the physical activity level of parturients in the postpartum period, the investigators have designed a pilot study to objectively measure their PA. Patients having a normal spontaneous vaginal delivery will serve as our control group. These patients are going through the same physiologic changes that their counterparts (CD patients) are going through, the only difference being the stress of surgery in the CD group.The use of Fitness trackers (i.e Fitbit(R), Actigraph GT3X +) has been used to measure and promote physical activity in a cardiac rehabilitation population, as well as in parturients self-identified as inactive. The investigators intend to use the Actigraph GT3X+ to measure the level of physical activity of 50 parturients (25 NSVD and 25 post CD). The information obtained, will help us tailor the anesthetic/analgesic management of parturients in such a way that promotes early ambulation and recovery. The investigators estimate that we need approximately a total of 50 patients, 25 per group to assess if there is a difference in the level of PA between parturients after a NSVD or CD. We will aim to recruit 60 patients 30 per group to account for missing data, protocol violations, equipment malfunction or patients drop outs.This will be a pilot, prospective study aimed at measuring the physical activity (PA) of American Society of Anesthesiologists (ASA) Classification I and II women aged 18 years and older, after a normal spontaneous vaginal (NSVD) or cesarean delivery (CD). Subjects will be ASA I and II women aged 18 years and older, knowing to have had either a NSVD or CD (under neuraxial anesthesia). After delivery, and assuring that mother and baby are stable, patients will be approached by a member of the study team to discuss the study and obtain informed consent. After obtaining informed consent, patients will be divided into Two (2) groups depending on the mode of delivery. Group 1 will be NSVD and group 2 will be CD patients. Patients will be provided with a fitbit- based Actigraph GT3X + hardware, 3 hours after delivery. Patients will be evaluated every 12 hours after delivery for a period of 48 hours. During these evaluation points, pain (visual analogue scores), factors affecting mobility, and level of satisfaction with their analgesia will be assessed. After 48 hours the Actigraph GT3X + will be interrogated and objective data, such as mean daily steps, will be obtained using the aforementioned software.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
District of Columbia
-
Washington, District of Columbia, Förenta staterna, 20037
- George Washington University
-
-
New Jersey
-
Newark, New Jersey, Förenta staterna, 07103
- University Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Women 18-45 years old giving birth after receiving a neuraxial analgesia/anesthesia technique. American Society of Anesthesiologists classification 1-2.
Exclusion Criteria:
- History of chronic pain
- Recent use of opioids (other than postpartum)
- Emergency case requiring general anesthesia (GA) or conversion to GA
- BMI > 45
- Need to perform more extensive surgery (i.e Hysterectomy) Need for the neonate to be admitted to NICU (This will prompt mothers to walk more frequently, and longer distances to visit the baby)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: normal spontaneous vaginal delivery
Both groups will be asked to wear a fitness tracker (Actigraph GT3X+).
|
following delivery a ActiGraph will be offered to patients to track their steps
|
Experimentell: Cesarean Delivery
Both groups will be asked to wear a fitness tracker (Actigraph GT3X+).
|
following delivery a ActiGraph will be offered to patients to track their steps
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Steps
Tidsram: from 6 hours the after delivery until discharge or 48 hours whatever happens first
|
This will be measured in the numbers of steps registered by the accelerometer
|
from 6 hours the after delivery until discharge or 48 hours whatever happens first
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Pain Score at Rest
Tidsram: 6 hours following delivery until 48 hours
|
This outcome will be measured using a visual analogue score (VAS).
Patient will mark their pain on a 0-100 mm line with 0 been no pain and 100 mm worst pain.
|
6 hours following delivery until 48 hours
|
Satisfaction Scores
Tidsram: 6 hours following delivery until 48 hours
|
This outcome will be measured using a visual analogue score (VAS).
Patient will mark their satisfaction on a 0-100 mm line with 0 been not satisfied at all and 100 mm extremely satisfied.
|
6 hours following delivery until 48 hours
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Studierektor: Antonio Gonzalez-Fiol, MD, Yale New Haven Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20160001283
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Postpartum sjukdom
-
The University of Texas Health Science Center,...AvslutadPostpartum | Physician RoundsFörenta staterna
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...AvslutadPostpartumFörenta staterna, Guatemala
-
Assistance Publique Hopitaux De MarseilleOkänd
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalAvslutadPostpartum depression | Postpartum ångest | Blues efter förlossningen | Postpartum humörstörningKanada
-
Western Kentucky UniversityRekryteringGraviditetsrelaterad | PostpartumFörenta staterna
-
London School of Hygiene and Tropical MedicineDepartment for International Development, United Kingdom; Economic and... och andra samarbetspartnersAvslutad
-
FHI 360Ghana Health Services; Ministry of Health, ZambiaAvslutad
-
Sao Marcos UniversityAvslutad
-
Baylor College of MedicineTexas Department of Family Protective ServicesRekrytering
Kliniska prövningar på Actigraph
-
VA Office of Research and DevelopmentAvslutadSjälvmordstankar | Suicidalt beteende | Symtom på mental hälsa | Sjukhusinläggningar för mental hälsaFörenta staterna
-
IRCCS Fondazione Stella MarisMinistry of Health, Italy; The University of Queensland; Scuola Superiore...Avslutad
-
Newcastle UniversityRekrytering
-
M.D. Anderson Cancer CenterAvslutad
-
NYU Langone HealthIndragen
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin,... och andra samarbetspartnersOkänd
-
University of South FloridaRekryteringLungsjukdomar, interstitiellFörenta staterna
-
Klinik ValensAvslutad
-
Melissa BatesRekrytering
-
Centre Hospitalier Universitaire de BesanconOkänd